StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
30
Publishing Date
2022 - 03 - 17
1
2022 - 03 - 15
1
2022 - 03 - 08
1
2022 - 03 - 01
2
2022 - 02 - 23
1
2022 - 02 - 22
2
2022 - 02 - 21
1
2022 - 02 - 17
1
2022 - 02 - 16
1
2022 - 02 - 14
3
2022 - 01 - 31
1
2022 - 01 - 28
1
2022 - 01 - 26
1
2022 - 01 - 25
1
2022 - 01 - 22
1
2022 - 01 - 20
1
2022 - 01 - 12
1
2022 - 01 - 06
2
2022 - 01 - 05
1
2022 - 01 - 03
1
2021 - 12 - 16
2
2021 - 12 - 14
1
2021 - 08 - 09
1
2021 - 06 - 15
1
Sector
Commercial services
1
Communications
1
Consumer durables
2
Electronic technology
2
Finance
1
Health technology
13
Information
1
Manufacturing
2
Non-energy minerals
1
Process industries
1
Producer manufacturing
2
Technology services
6
Tags
Acquisition
56
Agreement
49
Alliances
41
Application
43
Award
81
Awards
130
Biotech-bay
39
Brands
71
Business
56
Cancer
77
Care
44
Ceo
37
Ces
37
China
62
Collaboration
85
Companies
56
Conference
136
Designation
52
Device
32
Disease
36
Drug
66
Energy
97
Europe
53
Events
83
Financial
45
Global
253
Grant
38
Group
65
Growth
220
Health
116
Innovation
1023
International
53
Iot
36
Management
49
Market
331
Medical
55
Meeting
41
N/a
3597
Offering
36
One
35
Partnership
89
Patent
49
Platform
73
Program
50
Report
185
Research
188
Results
117
Services
44
Smart
38
Solution
46
Solutions
129
Study
46
System
60
Technology
302
Test
41
Therapeutics
57
Therapy
84
Treatment
117
Trial
69
Year
35
Entities
Accelerate diagnostics, inc.
1
Arcelormittal
1
Arcimoto, inc.
1
Astellas pharma inc
1
Autolus therapeutics plc
2
Bank of montreal
1
Carrier global corporation
1
Cnh industrial n.v.
1
Duck creek technologies, inc.
1
Eli lilly and company
6
Enlivex therapeutics ltd.
1
Forrester research, inc.
1
I-mab
1
Incyte corporation
6
International business machines corporation
2
Kyndryl holdings inc
1
Marrone bio innovations, inc.
1
Morphosys ag
1
Nxp semiconductors n.v.
1
Orange
1
Plus therapeutics, inc.
1
Raytheon technologies corporation
1
Rev group, inc.
1
Rimini street, inc.
1
Unity software inc.
1
Veeva systems inc.
1
Symbols
ALPMF
1
ALPMY
1
AMSIY
1
AMSYF
1
ARCXF
1
AUTL
2
AXDX
1
BMO
1
CARR
1
CNHI
1
DCT
1
ENLV
1
FNCTF
1
FORR
1
FUV
1
IBM
2
IMAB
1
INCY
6
KD
1
LLY
6
MBII
1
MOR
1
MPSYF
1
MT
1
NXPI
1
PSTV
1
REVG
1
RMNI
1
RTX
1
U
1
VEEV
1
Exchanges
Nasdaq
21
Nyse
16
Crawled Date
2022 - 03 - 17
1
2022 - 03 - 15
1
2022 - 03 - 08
1
2022 - 03 - 01
2
2022 - 02 - 23
2
2022 - 02 - 22
1
2022 - 02 - 21
1
2022 - 02 - 17
1
2022 - 02 - 16
1
2022 - 02 - 14
3
2022 - 01 - 31
1
2022 - 01 - 28
1
2022 - 01 - 26
1
2022 - 01 - 25
1
2022 - 01 - 22
1
2022 - 01 - 20
1
2022 - 01 - 12
1
2022 - 01 - 06
2
2022 - 01 - 05
1
2022 - 01 - 03
1
2021 - 12 - 16
2
2021 - 12 - 14
1
2021 - 08 - 09
1
2021 - 06 - 15
1
Crawled Time
00:00
1
00:20
1
01:00
3
02:00
1
03:00
1
10:00
1
12:00
3
12:30
1
13:00
1
14:00
2
14:30
1
15:00
6
15:30
1
17:00
1
19:00
2
20:00
1
21:00
1
22:00
1
23:00
1
Source
www.arcimoto.com
1
www.biospace.com
8
www.globenewswire.com
4
www.marronebio.com
1
www.prnewswire.com
14
www.revgroup.com
1
www.riministreet.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
innovation
tags :
Cel
save search
Digital Technologies to Accelerate Innovation in 2022
Published:
2022-03-17
(Crawled : 15:00)
- riministreet.com
RMNI
4
|
$2.8
-0.36%
160K
|
Technology Services
|
-48.81%
|
O:
-1.1%
H:
2.5%
C:
2.03%
cel
technology
Skybox Security celebrates 20 years of cybersecurity innovation
Published:
2022-03-15
(Crawled : 15:30)
- prnewswire.com
FORR
4
|
$18.68
-1.53%
-1.72%
96K
|
Commercial Services
|
-63.9%
|
O:
0.97%
H:
0.63%
C:
0.19%
cybersecurity
cel
security
Arcimoto to Discuss Accelerating Pace of Electric Vehicle Innovation at Two Investor Conferences in March
Published:
2022-03-08
(Crawled : 22:00)
- arcimoto.com
FUV
|
$0.4202
0.29%
0.6%
24K
|
Consumer Durables
|
-94.1%
|
O:
1.97%
H:
6.2%
C:
4.96%
conference
cel
electric vehicle
AnHeart Therapeutics and Innovent Biologics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1 Fusion-Positive Non-Small Cell Lung Cancer
Published:
2022-03-01
(Crawled : 15:00)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
207.51%
|
O:
1.26%
H:
0.0%
C:
0.0%
INCY
|
$51.74
0.17%
0.14%
1.6M
|
Health Technology
|
-23.69%
|
O:
0.44%
H:
2.1%
C:
0.88%
heart
therapeutics
cel
lung cancer
positive
cancer
designation
Innovent Biologics and AnHeart Therapeutics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer
Published:
2022-03-01
(Crawled : 02:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
207.51%
|
O:
1.26%
H:
0.0%
C:
0.0%
INCY
|
$51.74
0.17%
0.14%
1.6M
|
Health Technology
|
-23.69%
|
O:
0.44%
H:
2.1%
C:
0.88%
heart
therapeutics
cel
lung cancer
positive
cancer
designation
Kyndryl and AWS Establish Strategic Partnership to Accelerate Cloud Adoption and Innovation for Customers
Published:
2022-02-23
(Crawled : 14:30)
- prnewswire.com
KD
|
$20.23
-1.41%
-0.89%
1.5M
|
Information
|
35.23%
|
O:
0.33%
H:
1.07%
C:
-1.87%
partnership
cel
CNH Industrial Ventures established to accelerate new technology adoption and nurture disruptive innovation
Published:
2022-02-22
(Crawled : 00:00)
- globenewswire.com
CNHI
|
$11.4
-1.55%
-0.44%
14M
|
Producer Manufacturing
|
-27.43%
|
O:
-3.95%
H:
2.88%
C:
-1.13%
technology
trial
cel
new technology
Plus Therapeutics Partners with Medidata to Apply Innovative Synthetic Control ArmⓇ Solution to Accelerate Brain Cancer Clinical Trial
Published:
2022-02-22
(Crawled : 19:00)
- biospace.com/
PSTV
|
News
|
$1.6
-1.84%
-5.16%
8.5K
|
Health Technology
|
56.86%
|
O:
-4.9%
H:
13.4%
C:
4.12%
control
brain cancer
trial
therapeutics
cel
cancer
train
Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345
Published:
2022-02-21
(Crawled : 01:00)
- prnewswire.com
INCY
|
$51.74
0.17%
0.14%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
ibi345
car-t
cel
t-cell
Carrier Launches Corporate Venture Capital Group to Accelerate Sustainable Innovation and Disruptive Building & Cold Chain Technology
Published:
2022-02-17
(Crawled : 15:00)
- prnewswire.com
RTX
|
$101.02
-0.36%
0.61%
6.8M
|
Electronic Technology
|
6.62%
|
O:
-0.82%
H:
1.28%
C:
0.42%
CARR
|
$54.77
-0.67%
0.11%
4.5M
|
Producer Manufacturing
|
19.98%
|
O:
-1.07%
H:
0.75%
C:
-1.28%
technology
cel
group
With "Let's create," IBM Launches Brand Campaign to Accelerate Innovation with Clients and Partners
Published:
2022-02-16
(Crawled : 12:00)
- prnewswire.com
IBM
|
$184.1
1.05%
-8.35%
5.7M
|
Technology Services
|
41.68%
|
O:
-0.38%
H:
0.76%
C:
-0.21%
cel
Celebrating Excellence and the Advancement of Innovation Across the Global Insurance Industry
Published:
2022-02-14
(Crawled : 15:00)
- globenewswire.com
DCT
|
$18.99
0.0%
0
|
Technology Services
|
-18.79%
|
O:
-0.6%
H:
4.47%
C:
2.8%
insurance
cel
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by Innovent and IASO Bio
Published:
2022-02-14
(Crawled : 01:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
214.08%
|
O:
-2.3%
H:
1.23%
C:
0.29%
INCY
|
$51.74
0.17%
0.14%
1.6M
|
Health Technology
|
-22.9%
|
O:
-0.94%
H:
0.21%
C:
-0.69%
fda
car-t
drug
drug designation
cel
orphan drug
therapy
grant
t-cell
designation
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by IASO Bio and Innovent
Published:
2022-02-14
(Crawled : 01:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
214.08%
|
O:
-2.3%
H:
1.23%
C:
0.29%
INCY
|
$51.74
0.17%
0.14%
1.6M
|
Health Technology
|
-22.9%
|
O:
-0.94%
H:
0.21%
C:
-0.69%
fda
car-t
drug
drug designation
cel
orphan drug
therapy
grant
t-cell
designation
BMO announces plan to partner with Breakthrough Energy Catalyst to accelerate climate innovation
Published:
2022-01-31
(Crawled : 03:00)
- prnewswire.com
BMO
|
$92.84
-1.05%
0.0%
350K
|
Finance
|
-17.88%
|
O:
-1.29%
H:
1.81%
C:
1.42%
ces
cel
energy
I-Mab Announces Partnership Agreement to Localize Manufacturing and Accelerate Commercialization of Innovative Biologics Drugs
Published:
2022-01-28
(Crawled : 14:00)
- biospace.com/
MOR
|
News
|
$18.05
0.06%
0.17%
130K
|
Health Technology
|
142.61%
|
O:
0.0%
H:
1.88%
C:
1.75%
IMAB
|
$1.81
0.56%
0.28%
110K
|
Health Technology
|
-91.34%
|
O:
0.86%
H:
7.74%
C:
5.84%
partnership
commercialization
drug
cel
University Lab Partners at UCI Research Park Celebrates 2-Years of Supporting Life Science Innovation with 36 Resident Companies
Published:
2022-01-26
(Crawled : 19:00)
- prnewswire.com
FNCTF
|
News
|
$11.16
1.13%
-20.84%
0
|
Communications
|
Email alert
Add to watchlist
research
cel
life science
ArcelorMittal makes US$5 million investment in H2Pro via XCarb™ innovation fund
Published:
2022-01-25
(Crawled : 21:00)
- globenewswire.com
AMSYF
|
News
|
$26.89
-10.71%
200
|
Non-Energy Minerals
|
-12.92%
|
O:
-0.91%
H:
0.0%
C:
0.0%
MT
|
News
|
$25.2
0.04%
0.08%
960K
|
Non-Energy Minerals
|
-16.78%
|
O:
1.7%
H:
0.29%
C:
-2.99%
cel
Innovent and Eli Lilly and Company Announced Final Clinical Results and Biomarker Analysis of Phase Ib Study of TYVYT® (Sintilimab Injection) Plus Bevacizumab Biosimilar Injection for Advanced Hepatocellular Carcinoma at ASCO GI Annual Meeting 2022
Published:
2022-01-22
(Crawled : 00:20)
- prnewswire.com
INCY
|
$51.74
0.17%
0.14%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
tyvyt
cel
asco
injection
results
biosimilar
biomarkers
LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments
Published:
2022-01-20
(Crawled : 12:30)
- prnewswire.com
VEEV
|
$200.52
-0.29%
-0.38%
550K
|
Technology Services
|
-9.18%
|
O:
0.79%
H:
3.8%
C:
0.06%
treatment
cel
← Previous
1
2
Next →
Gainers vs Losers
61%
39%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
RILY
|
$29.75
36.97%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.